Moreover, preclinical evidence derived from a TME-mimicking tissue culture system enriched with Fas molecules and PBMCs treated with an anti-Fas monoclonal antibody (mAb) revealed that blocking the Fas/FasL pathway could significantly increase apoptosis and reduce stemness of BC cells [59]. This evidence concerns the gene FAS and breast cancer.